Biosafety level 2 model of pneumonic plague and protection studies with F1 and Psa
- Autores
- Galvan, Estela Maria; Nair, Manoj Kumar Mohan; Chen, Huaiqing; Del Piero, Fabio; Schifferli, Dieter M.
- Año de publicación
- 2010
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Attenuated Yersinia pestis pgm strains, such as KIM5, lack the siderophore yersiniabactin. Strain KIM5 does not induce significant pneumonia when delivered intranasally. In this study, mice were found to develop pneumonia after intranasal challenge with strain KIM5 when they were injected intraperitoneally with iron dextran, though not with iron sulfate. KIM5-infected mice treated daily with 4 mg iron dextran died in 3 days with severe pneumonia. Pneumonia was less severe if 4 mg iron dextran was administered only once before infection. The best-studied experimental vaccine against plague currently consists of the Yersinia pestis capsular antigen F1 and the type 3 secreted protein LcrV. The F1 antigen was shown to be protective against KIM5 infections in mice administered iron dextran doses leading to light or severe pneumonia, supporting the use of an iron dextran-treated model of pneumonic plague. Since F1 has been reported to be incompletely protective in some primates, and bacterial isolates lacking F1 are still virulent, there has been considerable interest in identifying additional protective subunit immunogens. Here we showed that the highly conserved Psa fimbriae of Y. pestis (also called pH 6 antigen) are expressed in murine organs after infection through the respiratory tract. Studies with iron dextran-treated mice showed that vaccination with the Psa fimbrial protein together with an adjuvant afforded incomplete but significant protection in the mouse model described. Therefore, further investigations to fully characterize the protective properties of the Psa fimbriae are warranted.
Fil: Galvan, Estela Maria. Fundación Instituto Leloir; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Investigaciones Bioquimicas de Buenos Aires; Argentina. University of Pennsylvania School of Veterinary Medicine. Department of Pathobiology; Estados Unidos
Fil: Nair, Manoj Kumar Mohan. University of Pennsylvania School of Veterinary Medicine. Department of Pathobiology; Estados Unidos
Fil: Chen, Huaiqing. University of Massachusetts Medical School. Department of Medicine; Estados Unidos
Fil: Del Piero, Fabio. University of Pennsylvania School of Veterinary Medicine. Department of Pathobiology; Estados Unidos
Fil: Schifferli, Dieter M.. University of Pennsylvania School of Veterinary Medicine. Department of Pathobiology; Estados Unidos - Materia
-
Yersinia Pestis
Pneumonic Plague
Iron Dextran
Psa And F1 - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/12782
Ver los metadatos del registro completo
id |
CONICETDig_d00a1b66a3ac7584493d62e7447ac538 |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/12782 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Biosafety level 2 model of pneumonic plague and protection studies with F1 and PsaGalvan, Estela MariaNair, Manoj Kumar MohanChen, HuaiqingDel Piero, FabioSchifferli, Dieter M.Yersinia PestisPneumonic PlagueIron DextranPsa And F1https://purl.org/becyt/ford/1.6https://purl.org/becyt/ford/1Attenuated Yersinia pestis pgm strains, such as KIM5, lack the siderophore yersiniabactin. Strain KIM5 does not induce significant pneumonia when delivered intranasally. In this study, mice were found to develop pneumonia after intranasal challenge with strain KIM5 when they were injected intraperitoneally with iron dextran, though not with iron sulfate. KIM5-infected mice treated daily with 4 mg iron dextran died in 3 days with severe pneumonia. Pneumonia was less severe if 4 mg iron dextran was administered only once before infection. The best-studied experimental vaccine against plague currently consists of the Yersinia pestis capsular antigen F1 and the type 3 secreted protein LcrV. The F1 antigen was shown to be protective against KIM5 infections in mice administered iron dextran doses leading to light or severe pneumonia, supporting the use of an iron dextran-treated model of pneumonic plague. Since F1 has been reported to be incompletely protective in some primates, and bacterial isolates lacking F1 are still virulent, there has been considerable interest in identifying additional protective subunit immunogens. Here we showed that the highly conserved Psa fimbriae of Y. pestis (also called pH 6 antigen) are expressed in murine organs after infection through the respiratory tract. Studies with iron dextran-treated mice showed that vaccination with the Psa fimbrial protein together with an adjuvant afforded incomplete but significant protection in the mouse model described. Therefore, further investigations to fully characterize the protective properties of the Psa fimbriae are warranted.Fil: Galvan, Estela Maria. Fundación Instituto Leloir; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Investigaciones Bioquimicas de Buenos Aires; Argentina. University of Pennsylvania School of Veterinary Medicine. Department of Pathobiology; Estados UnidosFil: Nair, Manoj Kumar Mohan. University of Pennsylvania School of Veterinary Medicine. Department of Pathobiology; Estados UnidosFil: Chen, Huaiqing. University of Massachusetts Medical School. Department of Medicine; Estados UnidosFil: Del Piero, Fabio. University of Pennsylvania School of Veterinary Medicine. Department of Pathobiology; Estados UnidosFil: Schifferli, Dieter M.. University of Pennsylvania School of Veterinary Medicine. Department of Pathobiology; Estados UnidosAmerican Society For Microbiology2010-08info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/12782Galvan, Estela Maria; Nair, Manoj Kumar Mohan; Chen, Huaiqing; Del Piero, Fabio; Schifferli, Dieter M.; Biosafety level 2 model of pneumonic plague and protection studies with F1 and Psa; American Society For Microbiology; Infection And Immunity; 78; 8; 8-2010; 3443-34530019-9567enginfo:eu-repo/semantics/altIdentifier/url/http://iai.asm.org/content/78/8/3443info:eu-repo/semantics/altIdentifier/doi/10.1128/IAI.00382-10info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T09:42:27Zoai:ri.conicet.gov.ar:11336/12782instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 09:42:27.99CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Biosafety level 2 model of pneumonic plague and protection studies with F1 and Psa |
title |
Biosafety level 2 model of pneumonic plague and protection studies with F1 and Psa |
spellingShingle |
Biosafety level 2 model of pneumonic plague and protection studies with F1 and Psa Galvan, Estela Maria Yersinia Pestis Pneumonic Plague Iron Dextran Psa And F1 |
title_short |
Biosafety level 2 model of pneumonic plague and protection studies with F1 and Psa |
title_full |
Biosafety level 2 model of pneumonic plague and protection studies with F1 and Psa |
title_fullStr |
Biosafety level 2 model of pneumonic plague and protection studies with F1 and Psa |
title_full_unstemmed |
Biosafety level 2 model of pneumonic plague and protection studies with F1 and Psa |
title_sort |
Biosafety level 2 model of pneumonic plague and protection studies with F1 and Psa |
dc.creator.none.fl_str_mv |
Galvan, Estela Maria Nair, Manoj Kumar Mohan Chen, Huaiqing Del Piero, Fabio Schifferli, Dieter M. |
author |
Galvan, Estela Maria |
author_facet |
Galvan, Estela Maria Nair, Manoj Kumar Mohan Chen, Huaiqing Del Piero, Fabio Schifferli, Dieter M. |
author_role |
author |
author2 |
Nair, Manoj Kumar Mohan Chen, Huaiqing Del Piero, Fabio Schifferli, Dieter M. |
author2_role |
author author author author |
dc.subject.none.fl_str_mv |
Yersinia Pestis Pneumonic Plague Iron Dextran Psa And F1 |
topic |
Yersinia Pestis Pneumonic Plague Iron Dextran Psa And F1 |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/1.6 https://purl.org/becyt/ford/1 |
dc.description.none.fl_txt_mv |
Attenuated Yersinia pestis pgm strains, such as KIM5, lack the siderophore yersiniabactin. Strain KIM5 does not induce significant pneumonia when delivered intranasally. In this study, mice were found to develop pneumonia after intranasal challenge with strain KIM5 when they were injected intraperitoneally with iron dextran, though not with iron sulfate. KIM5-infected mice treated daily with 4 mg iron dextran died in 3 days with severe pneumonia. Pneumonia was less severe if 4 mg iron dextran was administered only once before infection. The best-studied experimental vaccine against plague currently consists of the Yersinia pestis capsular antigen F1 and the type 3 secreted protein LcrV. The F1 antigen was shown to be protective against KIM5 infections in mice administered iron dextran doses leading to light or severe pneumonia, supporting the use of an iron dextran-treated model of pneumonic plague. Since F1 has been reported to be incompletely protective in some primates, and bacterial isolates lacking F1 are still virulent, there has been considerable interest in identifying additional protective subunit immunogens. Here we showed that the highly conserved Psa fimbriae of Y. pestis (also called pH 6 antigen) are expressed in murine organs after infection through the respiratory tract. Studies with iron dextran-treated mice showed that vaccination with the Psa fimbrial protein together with an adjuvant afforded incomplete but significant protection in the mouse model described. Therefore, further investigations to fully characterize the protective properties of the Psa fimbriae are warranted. Fil: Galvan, Estela Maria. Fundación Instituto Leloir; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Investigaciones Bioquimicas de Buenos Aires; Argentina. University of Pennsylvania School of Veterinary Medicine. Department of Pathobiology; Estados Unidos Fil: Nair, Manoj Kumar Mohan. University of Pennsylvania School of Veterinary Medicine. Department of Pathobiology; Estados Unidos Fil: Chen, Huaiqing. University of Massachusetts Medical School. Department of Medicine; Estados Unidos Fil: Del Piero, Fabio. University of Pennsylvania School of Veterinary Medicine. Department of Pathobiology; Estados Unidos Fil: Schifferli, Dieter M.. University of Pennsylvania School of Veterinary Medicine. Department of Pathobiology; Estados Unidos |
description |
Attenuated Yersinia pestis pgm strains, such as KIM5, lack the siderophore yersiniabactin. Strain KIM5 does not induce significant pneumonia when delivered intranasally. In this study, mice were found to develop pneumonia after intranasal challenge with strain KIM5 when they were injected intraperitoneally with iron dextran, though not with iron sulfate. KIM5-infected mice treated daily with 4 mg iron dextran died in 3 days with severe pneumonia. Pneumonia was less severe if 4 mg iron dextran was administered only once before infection. The best-studied experimental vaccine against plague currently consists of the Yersinia pestis capsular antigen F1 and the type 3 secreted protein LcrV. The F1 antigen was shown to be protective against KIM5 infections in mice administered iron dextran doses leading to light or severe pneumonia, supporting the use of an iron dextran-treated model of pneumonic plague. Since F1 has been reported to be incompletely protective in some primates, and bacterial isolates lacking F1 are still virulent, there has been considerable interest in identifying additional protective subunit immunogens. Here we showed that the highly conserved Psa fimbriae of Y. pestis (also called pH 6 antigen) are expressed in murine organs after infection through the respiratory tract. Studies with iron dextran-treated mice showed that vaccination with the Psa fimbrial protein together with an adjuvant afforded incomplete but significant protection in the mouse model described. Therefore, further investigations to fully characterize the protective properties of the Psa fimbriae are warranted. |
publishDate |
2010 |
dc.date.none.fl_str_mv |
2010-08 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/12782 Galvan, Estela Maria; Nair, Manoj Kumar Mohan; Chen, Huaiqing; Del Piero, Fabio; Schifferli, Dieter M.; Biosafety level 2 model of pneumonic plague and protection studies with F1 and Psa; American Society For Microbiology; Infection And Immunity; 78; 8; 8-2010; 3443-3453 0019-9567 |
url |
http://hdl.handle.net/11336/12782 |
identifier_str_mv |
Galvan, Estela Maria; Nair, Manoj Kumar Mohan; Chen, Huaiqing; Del Piero, Fabio; Schifferli, Dieter M.; Biosafety level 2 model of pneumonic plague and protection studies with F1 and Psa; American Society For Microbiology; Infection And Immunity; 78; 8; 8-2010; 3443-3453 0019-9567 |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/http://iai.asm.org/content/78/8/3443 info:eu-repo/semantics/altIdentifier/doi/10.1128/IAI.00382-10 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
American Society For Microbiology |
publisher.none.fl_str_mv |
American Society For Microbiology |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1844613338393214976 |
score |
13.070432 |